FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073683411> ?p ?o ?g. }

• W2073683411 endingPage "499" @default.
• W2073683411 startingPage "491" @default.
• W2073683411 abstract "Quinupristin–dalfopristin and linezolid are widely used for the treatment of vancomycin-resistant Enterococcus faecium (VREF) infections. Increasing resistance of VREF to quinupristin–dalfopristin and linezolid is a cause for concern. To determine the efficacy of and the rate of development of resistance to quinupristin–dalfopristin and linezolid, we analyzed all episodes of clinically significant VREF bacteraemia at a tertiary-care hospital from January 2003 to June 2007. The main outcomes were rates of 30-day mortality, microbiological response, and development of resistance. Fifty-two patients were treated with quinupristin–dalfopristin and 61 were treated with linezolid. Baseline demographic and clinical characteristics were similar between the 2 groups. There were no significant between-group differences in 30-day mortality (48% in the quinupristin–dalfopristin group vs 41% in the linezolid group; p = 0.45) or microbiological response (60% vs 66%; p = 0.51). However, prolonged bacteraemia (18% of 45 evaluable cases vs 4% of 55 evaluable cases; p = 0.04) and development of resistance in blood isolates (11% vs 0%; p = 0.02) were more frequently observed in the quinupristin–dalfopristin group than in the linezolid group. There was no significant difference between the efficacy of quinupristin–dalfopristin and linezolid. However, prolonged bacteraemia and the development of resistance were more common in quinupristin–dalfop ristin-treated patients." @default.
• W2073683411 created "2016-06-24" @default.
• W2073683411 creator A5002673171 @default.
• W2073683411 creator A5002973930 @default.
• W2073683411 creator A5003029603 @default.
• W2073683411 creator A5008696378 @default.
• W2073683411 creator A5011578742 @default.
• W2073683411 creator A5020573543 @default.
• W2073683411 creator A5035751489 @default.
• W2073683411 creator A5067286446 @default.
• W2073683411 creator A5084708203 @default.
• W2073683411 creator A5086479486 @default.
• W2073683411 creator A5088116135 @default.
• W2073683411 date "2010-06-04" @default.
• W2073683411 modified "2023-09-26" @default.
• W2073683411 title "Quinupristin–dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: Efficacy and development of resistance" @default.
• W2073683411 cites W1519064016 @default.
• W2073683411 cites W1965705252 @default.
• W2073683411 cites W1982820784 @default.
• W2073683411 cites W2009889907 @default.
• W2073683411 cites W2013238845 @default.
• W2073683411 cites W2037630809 @default.
• W2073683411 cites W2038442916 @default.
• W2073683411 cites W2043104846 @default.
• W2073683411 cites W2045774754 @default.
• W2073683411 cites W2063717688 @default.
• W2073683411 cites W2066180116 @default.
• W2073683411 cites W2073442625 @default.
• W2073683411 cites W2076952840 @default.
• W2073683411 cites W2097424391 @default.
• W2073683411 cites W2104851340 @default.
• W2073683411 cites W2113644422 @default.
• W2073683411 cites W2129491200 @default.
• W2073683411 cites W2130253433 @default.
• W2073683411 cites W2130824573 @default.
• W2073683411 cites W2137169574 @default.
• W2073683411 cites W2153039659 @default.
• W2073683411 cites W2155410164 @default.
• W2073683411 cites W2155952514 @default.
• W2073683411 cites W2164310171 @default.
• W2073683411 cites W4253391147 @default.
• W2073683411 doi "https://doi.org/10.3109/00365541003699623" @default.
• W2073683411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20524781" @default.
• W2073683411 hasPublicationYear "2010" @default.
• W2073683411 type Work @default.
• W2073683411 sameAs 2073683411 @default.
• W2073683411 citedByCount "18" @default.
• W2073683411 countsByYear W20736834112012 @default.
• W2073683411 countsByYear W20736834112013 @default.
• W2073683411 countsByYear W20736834112014 @default.
• W2073683411 countsByYear W20736834112015 @default.
• W2073683411 countsByYear W20736834112017 @default.
• W2073683411 countsByYear W20736834112018 @default.
• W2073683411 countsByYear W20736834112019 @default.
• W2073683411 countsByYear W20736834112021 @default.
• W2073683411 countsByYear W20736834112022 @default.
• W2073683411 countsByYear W20736834112023 @default.
• W2073683411 crossrefType "journal-article" @default.
• W2073683411 hasAuthorship W2073683411A5002673171 @default.
• W2073683411 hasAuthorship W2073683411A5002973930 @default.
• W2073683411 hasAuthorship W2073683411A5003029603 @default.
• W2073683411 hasAuthorship W2073683411A5008696378 @default.
• W2073683411 hasAuthorship W2073683411A5011578742 @default.
• W2073683411 hasAuthorship W2073683411A5020573543 @default.
• W2073683411 hasAuthorship W2073683411A5035751489 @default.
• W2073683411 hasAuthorship W2073683411A5067286446 @default.
• W2073683411 hasAuthorship W2073683411A5084708203 @default.
• W2073683411 hasAuthorship W2073683411A5086479486 @default.
• W2073683411 hasAuthorship W2073683411A5088116135 @default.
• W2073683411 hasConcept C126322002 @default.
• W2073683411 hasConcept C2777677444 @default.
• W2073683411 hasConcept C2777874012 @default.
• W2073683411 hasConcept C2778980435 @default.
• W2073683411 hasConcept C2779489039 @default.
• W2073683411 hasConcept C2780944852 @default.
• W2073683411 hasConcept C2781414143 @default.
• W2073683411 hasConcept C501593827 @default.
• W2073683411 hasConcept C523546767 @default.
• W2073683411 hasConcept C54355233 @default.
• W2073683411 hasConcept C71924100 @default.
• W2073683411 hasConcept C86803240 @default.
• W2073683411 hasConcept C89423630 @default.
• W2073683411 hasConceptScore W2073683411C126322002 @default.
• W2073683411 hasConceptScore W2073683411C2777677444 @default.
• W2073683411 hasConceptScore W2073683411C2777874012 @default.
• W2073683411 hasConceptScore W2073683411C2778980435 @default.
• W2073683411 hasConceptScore W2073683411C2779489039 @default.
• W2073683411 hasConceptScore W2073683411C2780944852 @default.
• W2073683411 hasConceptScore W2073683411C2781414143 @default.
• W2073683411 hasConceptScore W2073683411C501593827 @default.
• W2073683411 hasConceptScore W2073683411C523546767 @default.
• W2073683411 hasConceptScore W2073683411C54355233 @default.
• W2073683411 hasConceptScore W2073683411C71924100 @default.
• W2073683411 hasConceptScore W2073683411C86803240 @default.
• W2073683411 hasConceptScore W2073683411C89423630 @default.
• W2073683411 hasIssue "6-7" @default.
• W2073683411 hasLocation W20736834111 @default.
• W2073683411 hasLocation W20736834112 @default.

• next